| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 149, Issue 6 2021-2027, Copyright © 1992 by American Association of Immunologists
ARTICLES |
A Mackiewicz, H Schooltink, PC Heinrich and S Rose-John
Department of Cancer Immunology, Academy of Medicine at Great Poland Cancer Center, Poznan.
IL-6 is a major regulator of acute phase protein synthesis in the liver. It exerts its action via a plasma membrane receptor consisting of two subunits, a ligand binding 80-kDa glycoprotein and a 130-kDa glycoprotein involved in signal transduction. We genetically generated a soluble form of the 80-kDa subunit of the human IL-6R (shIL-6R) in mouse fibroblasts (NIH/3T3 cells). The shIL-6R added to human hepatoma cells (HepG2) amplified the induction of alpha 1-antichymotrypsin and haptoglobin by IL-6 at the mRNA and protein level. Moreover, a model for a liver permanently exposed to high IL-6 concentrations has been developed; HepG2 cells were stably transfected with human IL-6-cDNA; 10(6) of the transfected cells (HepG2-IL-6) synthesized and secreted 2 micrograms of IL-6 within 24 h. Incubation of these cells with endogenous or exogenous IL-6 did not result in acute-phase protein induction. However, these IL-6-desensitized cells responded to other cytokines such as leukemia inhibitory factor, transforming growth factor beta 1, and IFN-gamma, known to modulate acute phase protein synthesis in the liver. Incubation of HepG2-IL-6 cells with shIL-6R reconstituted their responsiveness to IL-6 in a dose- and time- dependent manner. The possible biologic role that might be played by the shIL-6R in disease is discussed.
This article has been cited by other articles:
|
|
 |
|
  L. A. Schaap, S. M. F. Pluijm, D. J. H. Deeg, T. B. Harris, S. B. Kritchevsky, A. B. Newman, L. H. Colbert, M. Pahor, S. M. Rubin, F. A. Tylavsky, et al. Higher Inflammatory Marker Levels in Older Persons: Associations With 5-Year Change in Muscle Mass and Muscle Strength J Gerontol A Biol Sci Med Sci, November 1, 2009; 64A(11): 1183 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Adam, B. Rabe, J. Suthaus, J. Grotzinger, S. Rose-John, and J. Scheller Unraveling Viral Interleukin-6 Binding to gp130 and Activation of STAT-Signaling Pathways Independently of the Interleukin-6 Receptor J. Virol., May 15, 2009; 83(10): 5117 - 5126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. K. Pedersen and M. A. Febbraio Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6 Physiol Rev, October 1, 2008; 88(4): 1379 - 1406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-Y. Youn, H.-S. Yoo, M.-J. Kim, S.-Y. Hwang, Y. Choi, S. V. Desiderio, and J.-Y. Yoo hCTR9, a Component of Paf1 Complex, Participates in the Transcription of Interleukin 6-responsive Genes through Regulation of STAT3-DNA Interactions J. Biol. Chem., November 30, 2007; 282(48): 34727 - 34734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kovaleva, I. Bussmeyer, B. Rabe, J. Grotzinger, E. Sudarman, J. Eichler, U. Conrad, S. Rose-John, and J. Scheller Abrogation of Viral Interleukin-6 (vIL-6)-Induced Signaling by Intracellular Retention and Neutralization of vIL-6 with an Anti-vIL-6 Single-Chain Antibody Selected by Phage Display. J. Virol., September 1, 2006; 80(17): 8510 - 8520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rose-John, J. Scheller, G. Elson, and S. A. Jones Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer J. Leukoc. Biol., August 1, 2006; 80(2): 227 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rivera, R. Talens-Visconti, R. Sirera, V. Bertomeu, A. Salvador, R. Cortes, F. G. de Burgos, V. Climent, R. Paya, L. Martinez-Dolz, et al. Soluble TNF-{alpha} and interleukin-6 receptors in the urine of heart failure patients. Their clinical value and relationship with plasma levels Eur J Heart Fail, December 1, 2004; 6(7): 877 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Terstegen, P. Gatsios, S. Ludwig, S. Pleschka, W. Jahnen-Dechent, P. C. Heinrich, and L. Graeve The Vesicular Stomatitis Virus Matrix Protein Inhibits Glycoprotein 130-Dependent STAT Activation J. Immunol., November 1, 2001; 167(9): 5209 - 5216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.J. HACKETT, A.P. J. THOMSON, and C.A. HART Cytokines, chemokines and other effector molecules involved in meningococcal disease J. Med. Microbiol., October 1, 2001; 50(10): 847 - 859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Jialal, D. Stein, D. Balis, S. M. Grundy, B. Adams-Huet, and S. Devaraj Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels Circulation, April 17, 2001; 103(15): 1933 - 1935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hess, H. Smola, U. Sandaradura de Silva, D. Hadaschik, D. Kube, S. E. Baldus, U. Flucke, and H. Pfister Loss of IL-6 Receptor Expression in Cervical Carcinoma Cells Inhibits Autocrine IL-6 Stimulation: Abrogation of Constitutive Monocyte Chemoattractant Protein-1 Production J. Immunol., August 15, 2000; 165(4): 1939 - 1948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Mullberg, T. Geib, T. Jostock, S. H. Hoischen, P. Vollmer, N. Voltz, D. Heinz, P. R. Galle, M. Klouche, and S. Rose-John IL-6 Receptor Independent Stimulation of Human gp130 by Viral IL-6 J. Immunol., May 1, 2000; 164(9): 4672 - 4677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Martens, J. Bode, P. Heinrich, and L Graeve The cytoplasmic domain of the interleukin-6 receptor gp80 mediates its basolateral sorting in polarized madin-darby canine kidney cells J. Cell Sci., January 10, 2000; 113(20): 3593 - 3602. [Abstract] [PDF]
|
|
|
|
 |
|
 B. Sporri, K. M. Muller, U. Wiesmann, and M. Bickel Soluble IL-6 receptor induces calcium flux and selectively modulates chemokine expression in human dermal fibroblasts Int. Immunol., July 1, 1999; 11(7): 1053 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gabay and I. Kushner Acute-Phase Proteins and Other Systemic Responses to Inflammation N. Engl. J. Med., February 11, 1999; 340(6): 448 - 454. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Peters, A. M. Muller, and S. Rose-John Interleukin-6 and Soluble Interleukin-6 Receptor: Direct Stimulation of gp130 and Hematopoiesis Blood, November 15, 1998; 92(10): 3495 - 3504. [Full Text] [PDF]
|
|
|
|
|
|
C. Renne, K.-J. Kallen, J. Mullberg, T. Jostock, J. Grotzinger, and S. Rose-John A New Type of Cytokine Receptor Antagonist Directly Targeting gp130 J. Biol. Chem., October 16, 1998; 273(42): 27213 - 27219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. P. Frick, L.-R. Tai, W. R. Baumbach, and H. M. Goodman Tissue Distribution, Turnover, and Glycosylation of the Long and Short Growth Hormone Receptor Isoforms in Rat Tissues Endocrinology, June 1, 1998; 139(6): 2824 - 2830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Silacci, J.-M. Dayer, A. Desgeorges, R. Peter, C. Manueddu, and P.-A. Guerne Interleukin (IL)-6 and Its Soluble Receptor Induce TIMP-1 Expression in Synoviocytes and Chondrocytes, and Block IL-1-induced Collagenolytic Activity J. Biol. Chem., May 29, 1998; 273(22): 13625 - 13629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Marz, J.-G. Cheng, R. A. Gadient, P. H. Patterson, T. Stoyan, U. Otten, and S. Rose-John Sympathetic neurons can produce and respond to interleukin 6 PNAS, March 17, 1998; 95(6): 3251 - 3256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kordula, R. E. Rydel, E. F. Brigham, F. Horn, P. C. Heinrich, and J. Travis Oncostatin M and the Interleukin-6 and Soluble Interleukin-6 Receptor Complex Regulate alpha 1-Antichymotrypsin Expression in Human Cortical Astrocytes J. Biol. Chem., February 13, 1998; 273(7): 4112 - 4118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Krebs, H. Griffin, G. Winter, and S. Rose-John Recombinant Human Single Chain Fv Antibodies Recognizing Human Interleukin-6. SPECIFIC TARGETING OF CYTOKINE-SECRETING CELLS J. Biol. Chem., January 30, 1998; 273(5): 2858 - 2865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kim and H. Baumann Transmembrane Domain of gp130 Contributes to Intracellular Signal Transduction in Hepatic Cells J. Biol. Chem., December 5, 1997; 272(49): 30741 - 30747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Emptoz-Bonneton, J. C. Crave, H. Lejeune, C. Brebant, and M. Pugeat Corticosteroid-Binding Globulin Synthesis Regulation by Cytokines and Glucocorticoids in Human Hepatoblastoma-Derived (HepG2) Cells J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3758 - 3762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Reed and A. Purohit Breast Cancer and the Role of Cytokines in Regulating Estrogen Synthesis: An Emerging Hypothesis Endocr. Rev., October 1, 1997; 18(5): 701 - 715. [Abstract] [Full Text]
|
|
|
|
|
|
G. L. Kukielka, C. W. Smith, A. M. Manning, K. A. Youker, L. H. Michael, and M. L. Entman Induction of Interleukin-6 Synthesis in the Myocardium : Potential Role in Postreperfusion Inflammatory Injury Circulation, October 1, 1995; 92(7): 1866 - 1875. [Abstract] [Full Text]
|
|
|
|
|
|
M. Ehlers, F. D. de Hon, H. K. Bos, U. Horsten, Gün. Kurapkat, H. S. van De Leur, J. Grötzinger, A. Wollmer, J. P. J. Brakenhoff, and S. Rose-John Combining Two Mutations of Human Interleukin-6 That Affect gp130 Activation Results in a Potent Interleukin-6 Receptor Antagonist on Human Myeloma Cells J. Biol. Chem., April 7, 1995; 270(14): 8158 - 8163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Hermanns, S. Radtke, F. Schaper, P. C. Heinrich, and I. Behrmann Non-redundant Signal Transduction of Interleukin-6-type Cytokines. THE ADAPTER PROTEIN Shc IS SPECIFICALLY RECRUITED TO THE ONCOSTATIN M RECEPTOR J. Biol. Chem., December 22, 2000; 275(52): 40742 - 40748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Terstegen, P. Gatsios, J. G. Bode, F. Schaper, P. C. Heinrich, and L. Graeve The Inhibition of Interleukin-6-dependent STAT Activation by Mitogen-activated Protein Kinases Depends on Tyrosine 759 in the Cytoplasmic Tail of Glycoprotein 130 J. Biol. Chem., June 16, 2000; 275(25): 18810 - 18817. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
